How to appeal a Carelon (formerly AIM Specialty Health) denial
Carelon Medical Benefits Management (an Elevance Health company, formerly AIM Specialty Health) runs prior authorization for Anthem, many Blue Cross Blue Shield plans, and other payers — covering advanced imaging, cardiology, oncology, radiation oncology, sleep, musculoskeletal, and genetic testing. An 'Anthem' or 'Blue' auth denial for these services is often really a Carelon decision, and the reconsideration starts there.
The most common Carelon (formerly AIM Specialty Health) denials
- Advanced imaging and cardiology studies denied against Carelon clinical guidelines
- Oncology, radiation oncology, and genetic testing denied for not meeting criteria
- MSK and sleep-study authorizations denied or approved for a different code
- Conservative-therapy or documentation requirements not shown as met
How to appeal to Carelon (formerly AIM Specialty Health)
What wins with Carelon (formerly AIM Specialty Health)
- Document the patient against Carelon's published clinical criteria — prior conservative care, symptoms, and earlier imaging carry these appeals
- Use the peer-to-peer early; specialist-to-specialist review reverses many imaging and cardiology denials
- Verify the auth covers the precise CPT and place of service, or the downstream claim denies even with an approval on file
- After Carelon upholds, move promptly — the plan-level appeal window is separate and shorter than practices expect
Common questions
How do I appeal a Carelon (formerly AIM Specialty Health) denial?
Carelon Medical Benefits Management (an Elevance Health company, formerly AIM Specialty Health) runs prior authorization for Anthem, many Blue Cross Blue Shield plans, and other payers — covering advanced imaging, cardiology, oncology, radiation oncology, sleep, musculoskeletal, and genetic testing. An 'Anthem' or 'Blue' auth denial for these services is often really a Carelon decision, and the reconsideration starts there. The path: start the reconsideration with Carelon through its provider portal (the former AIM ProviderPortal) — Carelon, not the Blue plan, made the authorization decision; request a peer-to-peer / clinical review with a Carelon physician for the fastest path to overturn a specialty-service denial; if Carelon upholds, the formal appeal moves to the health plan (Anthem or the local Blue) under that plan's process and deadline; confirm the authorization matches the exact code and site of service you'll bill.
What are the most common Carelon (formerly AIM Specialty Health) denials?
Advanced imaging and cardiology studies denied against Carelon clinical guidelines; Oncology, radiation oncology, and genetic testing denied for not meeting criteria; MSK and sleep-study authorizations denied or approved for a different code; Conservative-therapy or documentation requirements not shown as met.
How does Volari handle Carelon (formerly AIM Specialty Health) denials?
Volari identifies your written-off Carelon (formerly AIM Specialty Health) denials, builds each appeal with the payer-specific argument and documentation, files it through Carelon (formerly AIM Specialty Health)'s process, and follows it to payment. You pay 25% only on what's recovered.
Where Volari fits: Volari spots the Carelon-managed denials hiding inside Anthem and Blue Cross remittances, files the reconsideration and peer-to-peer against Carelon's own criteria, and escalates to the plan when Carelon upholds.
See what Carelon (formerly AIM Specialty Health) owes you.
Upload your remittances and Volari finds the Carelon (formerly AIM Specialty Health) denials and underpayments worth recovering. No risk, paid only on what we recover.